Acute Myeloid Leukemia Market In-Depth Outlook Size, Share & Major Stakeholders

January 2, 2025 akio01

How Big is the Acute Myeloid Leukemia Market?

The Global Acute Myeloid Leukemia (AML) Market is projected to grow at a CAGR of around 13% during the forecast period, i.e., 2022-27. The market growth is fueled mainly by surging instances of genetic mutations, the growing geriatric population, & sedentary lifestyles that have resulted in the rapid rise in AML patients worldwide. As a result, governments and pharmaceutical companies of different countries worldwide are actively participating & massively investing in developing new drugs for its treatment.

Market Statistics

Market Growth Rate (CAGR): 13% from 2022-2027

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/acute-myeloid-leukemia-market.html

Acute Myeloid Leukemia Market Segmentation:

The report has segmented the market into the following categories:

By Diagnosis

Blood Tests
Bone Marrow Biopsy
Imaging
Lumbar Puncture (Spinal Tap)

By Treatment

Chemotherapy
- Cytarabine
- Anthracycline
- Others (Cladribine (2-CdA), Fludarabine, etc.)
Targeted Therapy
- Midostaurin (Rydapt)
- Gilteritinib (Xospata)
- Ivosidenib (Tibsovo)
- Enasidenib (Idhifa)
Stem Cell Transplant

By End-User

Hospitals
Specialty Clinics
Others (Ambulatory Surgery Centers, etc.)

By Region

North America
South America
Europe
Middle East & Africa
Asia-Pacific

Browse Full Report Along with TOC and Figures – https://www.marknteladvisors.com/research-library/acute-myeloid-leukemia-market.html

Competitive Landscape:

AstraZeneca PLC
AbbVie Inc.
Baxter International Inc.
Bayer AG
Bristol Myers Squibb
Eisai Co. Ltd.
Eli Lilly and Company
F. Hoffmann-La Roche AG
Merck & Co., Inc.
Novartis International AG
Pfizer Inc.
Sanofi S.A.
Others.

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address*

Other Report:

Key Highlights of the Report:

Market Performance (2022-2027)
Strategic Recommendations
Current, Historical and Future Market Trends
Market Drivers and Leading Competitor
SWOT Analysis
Structure of the Market
Comprehensive Mapping and Recent Advancement

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Call +1 628 895 8081, +91 120 4278433

Email: sales@marknteladvisors.com